At a glance
- Originator Merck Frosst
- Class Benzoic acids
- Mechanism of Action Prostaglandin D agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Ischaemic heart disorders; Thrombosis
Most Recent Events
- 29 Nov 1999 New profile
- 29 Nov 1999 Preclinical development for Thrombosis in Canada (Unknown route)
- 29 Nov 1999 Preclinical development for Ischaemic heart disorders in Canada (Unknown route)